Early Access — free while we kick the tires
EdgarHawk

NEUP Neuphoria Therapeutics Inc. Insider Trading

1 filing analyzed · Latest 2025-10-23
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
October 2025
2025-10-23
high
Lynx1 Capital Management LP Buy
639,110 shares
$3,283,108
@ $5.14
Significance 7/10

10% owner Lynx1 Capital buys 639,110 shares at $5.14; stock now $4.05, down 63.3% in 30 days

Lynx1 Capital Management LP, already a 10% shareholder, purchased 639,110 shares at $5.14 on 2025-10-21, expanding holdings by 270.6% from 236,218 to 875,328 shares and committing $3,283,108.07 to the position. The purchase occurred during a severe downturn: the stock has since fallen 63.3% over the past 30 days and currently trades at $4.05, down 79.8% from its 52-week high of $20.00. While Lynx1's cross-ticker track record shows 20 prior buys with an 80.00% 90-day win rate and average 90-day return of +410.7%, those gains occurred at other stocks—this purchase at Neuphoria comes amid significant price deterioration and a company that reported full-year net income in the negative, despite a recent profitable quarter showing $15.0M revenue and $11.3M net income. The tension between the insider's established buy discipline across its portfolio and the sharply adverse price movement post-transaction warrants examination of whether fundamental developments precipitated the recent decline.

Insiders here also file at

Get alerts for NEUP

Add NEUP to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access